Lab-made virus mimics Covid-19 virus, can aid vaccine discovery
Image For Representation
Washington: Researchers have created a virus in the lab that infects cells and interacts with antibodies just like the Covid-19 virus but lacks the ability to cause severe disease.
This safer virus makes it possible for scientists who do not have access to high-level biosafety facilities to join the effort to find drugs or vaccines for Covid-19, according to the study, published in the journal Cell Host and Microbe.
“I’ve never had this many requests for a scientific material in such a short period of time, even before we published, people heard that we were working on this and started requesting the material,” said study co-senior author Sean Whelan from the Washington University in the US.
To create a model of Covid-19 virus that would be safer to handle, the research team started with vesicular stomatitis virus (VSV).
This virus is a workhorse of virology labs because it is fairly innocuous and easy to manipulate genetically.
Primarily a virus of cattle, horses and pigs, VSV occasionally infects people, causing a mild flu-like illness that lasts three to five days.
Viruses have proteins on their surfaces that they use to latch onto and infect cells. The researchers removed VSV’s surface-protein gene and replaced it with the one from Covid-19, known as spike.
The switch created a new virus that targets cells like SARS-CoV-2 but lacks the other genes needed to cause severe disease.
They dubbed the hybrid virus VSV-SARS-CoV-2.
Using serum from Covid-19 survivors and purified antibodies, the researchers showed that the hybrid virus was recognised by antibodies very much like a real SARS-CoV-2 virus that came from a Covid-19 patient.
“Humans certainly develop antibodies against other SARS-CoV-2 proteins, but it’s the antibodies against spike that seem to be most important for protection,” Whelan said.
“So as long as a virus has the spike protein, it looks to the human immune system like SARS-CoV-2, for all intents and purposes,” Whelan added.
The hybrid virus could help scientists evaluate a range of antibody-based preventives and treatments for Covid-19.
“Since the hybrid virus looks like SARS-CoV-2 to the immune system but does not cause severe disease, it is a potential vaccine candidate, the study authors noted.
IANS
The English Post Is Now On Telegram. Click Here To Subscribe
For Regular News Updates Join Our WhatsApp Group. Click Here To Join